Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT04984551
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Advanced Malignant Solid Neoplasm
- Hematopoietic and Lymphoid Cell Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Interventions
- Extension of Community Health (ECHO) Telementoring Clinic — OTHERParticipate in ECHO clinics presenting cases for guidance and feedback
- In-Country Workshops — OTHERIn-Country Workshops Participate in hands-on training and workshops
- Professional Oncology Educations Programs — OTHERReceive 5 core online lectures
- Medical Chart Review — OTHERMedical charts are reviewed for data collection
- Questionnaire Administration — OTHERComplete questionnaire(s)
Study Details
This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live. Understanding the experiences and satisfaction of patients and caregivers may help improve healthcare workforce capacity and increase access to specialty care for the world's rural and underserved populations.
Key Dates
- Start date
- Aug 24, 2020
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 312 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm I: ECHO Participants (ECHO clinics, workshop, education)Participants participate in online ECHO clinics over 1 hour twice monthly for 12 months and in-country workshops twice per year. Participants also receive 5 core lectures through an internet-based professional education curriculum.
- Experimental: Arm II: Patients (questionnaire, medical chart review)Patients complete 3 in-person or phone questionnaires over a total of 20 minutes every 3 months for 2 years about their symptoms, emotional and physical well-being, and their experience and satisfaction with outpatient oncology care. Patients' medical charts are reviewed for data collection. Patients complete a 15 minute interview in person or phone about the care they received by their physician at baseline, end of month 4 and month 12.
- Experimental: Arm III: Caregivers (questionnaire)Caregivers complete an in-person or phone questionnaire over 5 minutes up to 8 times about their experience and satisfaction with the cancer care their family member has received. Caregivers complete a 15-minute interview in person or by phone their family member received by their physician.
Primary Outcome Measure
Change in patients' quality of life [ Time Frame: Baseline up to 12 months ]
Central Contacts
- Sriram Yennu713-792-6085
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Sriram Yennu 713-792-6085 Sriram Yennu (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory FailureRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas